CN1304017C - Capsule for activating vital energy and promoting blood circulation - Google Patents

Capsule for activating vital energy and promoting blood circulation Download PDF

Info

Publication number
CN1304017C
CN1304017C CNB2005100435131A CN200510043513A CN1304017C CN 1304017 C CN1304017 C CN 1304017C CN B2005100435131 A CNB2005100435131 A CN B2005100435131A CN 200510043513 A CN200510043513 A CN 200510043513A CN 1304017 C CN1304017 C CN 1304017C
Authority
CN
China
Prior art keywords
vasculitis
present
grams
oryzanol
rutin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100435131A
Other languages
Chinese (zh)
Other versions
CN1706466A (en
Inventor
张兴惠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005100435131A priority Critical patent/CN1304017C/en
Publication of CN1706466A publication Critical patent/CN1706466A/en
Application granted granted Critical
Publication of CN1304017C publication Critical patent/CN1304017C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a qi circulating pulsation capsule. The present invention has a formula of the following proportion: 77% of ginseng, 20% of acetylsalicylic acid, 1% of oryzanol and 2% of rutin. The formula comprises the following weight: 385 grams of ginseng, 100 grams of acetylsalicylic acid, 5 grams of oryzanol and 10 grams of rutin. The preparation technology comprises the steps of ginseng impurity removal, cleaning, moistening, slice, dryness, sterilization, pulverization and sieving to prepare fine powder, namely ginseng powder. Raw powder of the acetylsalicylic acid, the oryzanol and the rutin are respectively sieved to obtain fine powder, the fine powder and the ginseng powder are evenly mixed and are encapsulated, and the mixed power can be prepared into 1000 capsules. The capsules are taken for 3 to 4 times every day, and 2 to 4 capsules are taken each time according to an illness state. Vasculitis belongs to an intractable disease, the present invention is used for treating the vasculitis by matching with blood circulation promoting pulsation capsules and spleen strengthening pulsation capsules according to the illness state, and the present invention is matched with ion acupoint introduction and self acupoint massage to obtain breakthrough treating effect. Therefore, the present invention can cure the vasculitis with confidence, a vasculitis patient has no need to carry out amputation, the present invention can make embolized blood vessels through, and a disappeared pulse is restored. The present invention has the advantages of wide clinic popularization value and application value.

Description

A kind of medicine that is used for the treatment of vasculitis and vessel embolism
Technical field:
The present invention relates to treat the Chinese and western medicine of vasculitis and vessel embolism use and a kind of medicine that is used for the treatment of vasculitis and vessel embolism that Chinese medicine and western medicine combines.
Background technology:
The traditional Chinese medical science claims that vasculitis is " gangrene of finger or toe ", and its pathogenesis and the cause of disease are the heresy of people's affection of exogenous wind-cold humidity of body void, invade in blood vessels, causes qi depression to blood stasis and falls ill.Doctor trained in Western medicine is thought due to smoking, immunocompromised and the endocrine disturbance.Chinese and western medicine does not still have effective Therapeutic Method at present, many vasculitis patient amputation even death.
Summary of the invention:
The objective of the invention is to, overcome the deficiencies in the prior art, a kind of medicine that is used for the treatment of vasculitis and vessel embolism is provided, the vasculitis patient is treated based on the therapeutic scheme of the autonomic nerve of recovery paralysis, again various vasculitiss of each phase such as asthenic cold type, blood stasis type, heat-toxin type, deficiency in both Qi and blood type are carried out dialectical single or associating " the pulsation capsule of invigorating blood circulation " and " spleen invigorating pulsation capsule " executed and controlled, cooperate the ion acupuncture point to import or self-acupoint massage, now treat vasculitis patient more than 10 ten thousand examples, obtained breakthrough curative effect.
A kind of medicine that is used for the treatment of vasculitis and vessel embolism of the present invention is made up of Radix Ginseng, aspirin, oryzanol and rutin.A kind of formula proportion that is used for the treatment of the medicine of vasculitis and vessel embolism of the present invention is: Radix Ginseng 77%, aspirin 20%, oryzanol 1% and rutin 2%.Its processing technology is: Radix Ginseng removed impurity, cleans, run through, and section, dry sterilization is pulverized, is sieved, and makes fine powder, i.e. the Radix Ginseng powder.The former powder of aspirin, oryzanol and rutin is sieved respectively, get fine powder and Radix Ginseng powder's mix homogeneously, incapsulate.The concrete use every day 3~4 times looked each 2~4 of the state of an illness.A kind of pharmacology that is used for the treatment of the medicine of vasculitis and vessel embolism of the present invention is: Radix Ginseng circulation of qi promoting, enhancing human body immunity power, oryzanol is regulated autonomic nerve, the aspirin anti-platelet aggregation, prevention thrombosis and antiinflammatory, rutin is kept blood vessel elasticity.All medicines also with having QI invigorating, reducing blood viscosity, strengthen the effect of autonomic nerve to the regulatory function and the human body immunity improving power of blood vessel.
Vasculitis belongs to stubborn disease, use a kind of medicine series such as medicine treatment vasculitis that is used for the treatment of vasculitis and vessel embolism of the present invention, cooperate the ion acupuncture point to import or self-acupoint massage again, obtained breakthrough curative effect, more than the 10 ten thousand routine patients that cured facts have proved that vasculitis can be cured, and can make the blood vessel of thromboembolism logical again, the pulse that disappears recovers, so the present invention has clinic popularization and application values widely.With " the pulsation capsule of invigorating blood circulation " and " the spleen invigorating pulsation capsule " in addition that a kind of medicine that is used for the treatment of vasculitis and vessel embolism of the present invention is used, to look the state of an illness and use, effect is better.The present invention establishes the vasculitic cause of disease: the damaging flesh type of many reasons blood vessel autonomic nerve paralysis, and formulated the vasculitic new therapy of treatment of a whole set of serial combination of Chinese and Western medicine.Not being both of the new therapy and the simple traditional Chinese medical science, western medicine therapy: new therapy is the autonomic nerve with the recovery paralysis, and contraction and diastolic function of recovering its domination flesh type blood vessel are main.The traditional Chinese medical science is then based on blood circulation promoting and blood stasis dispelling, and doctor trained in Western medicine is based on thrombus, and blood stasis and thrombosis are to occur " mark " rather than " basis " in the vasculitis pathogenic process.The simple traditional Chinese medical science, the vasculitic failure of western medical treatment are exactly only to control " mark ", do not control " basis " and cause.
The specific embodiment:
Now in conjunction with the embodiments a kind of medicine that is used for the treatment of vasculitis and vessel embolism of the present invention is described in detail as follows: a kind of formula proportion that is used for the treatment of the medicine of vasculitis and vessel embolism of the present invention is: Radix Ginseng 77%, aspirin 20%, oryzanol 1% and rutin 2%.The weight of said prescription is: Radix Ginseng 385 grams, aspirin 100 grams, oryzanol 5 grams, rutin 10 grams.Its processing technology is: Radix Ginseng removed impurity, cleans, run through, and section, dry sterilization is pulverized, is sieved, and makes fine powder, i.e. the Radix Ginseng powder.The former powder of aspirin, oryzanol and rutin is sieved respectively, get fine powder and Radix Ginseng powder's mix homogeneously, incapsulate, make 1000.The concrete use every day 3~4 times looked each 2 to 4 of the state of an illness.A kind of pharmacology that is used for the treatment of the medicine of vasculitis and vessel embolism of the present invention is: Radix Ginseng circulation of qi promoting, enhancing human body immunity power, oryzanol is regulated autonomic nerve, the aspirin anti-platelet aggregation, prevention thrombosis and antiinflammatory, rutin is kept blood vessel elasticity.All medicines also with having QI invigorating, reducing blood viscosity, strengthen the effect of autonomic nerve to the regulatory function and the human body immunity improving power of blood vessel.Vasculitis belongs to stubborn disease, use the medicine series of a kind of medicine that is used for the treatment of vasculitis and vessel embolism of the present invention and, obtained breakthrough curative effect based on a kind of new method treatment vasculitis and vessel embolism that is used for the treatment of the medicine of vasculitis and vessel embolism.So the present invention has clinic popularization and application values widely.
Case is described below:
1, Huang Xiuliang, man, 51 years old, people from Tai, Shandong.Biped is suffered from vasculitis in the time of 29 years old, and left side foot is heavier, and through how tame hospital obstinate, the state of an illness runs down, and biped festers, and left side foot rots 1/3, and living maggot, hyperpyrexia, diarrhoea, and severe pain is lain awake all night unbearably, and the state of an illness is critical.It is hospital-made based on a kind of new therapy treatment that is used for the treatment of the medicine of vasculitis and vessel embolism to accept Jining vasculitis in June, 1986.After 3 years, the biped face that festers heals clinical cure.Over 15 years, follow up a case by regular visits to for six times and not see recurrence.Late result " excellent ".Telephone number: 0537-2336733.
2, Li Kaixun, man, 59 years old, first people from county in provincial boundaries, Anhui.Biped is suffered from vasculitis in the time of 40 years old, and through how tame hospital obstinate, sb.'s illness took a turn for the worse, and left sufficient mummification necrosis is more than 1/3, and the Plantar bone exposes, the pain groan, and night is with until dawn.Monthly income was in hospital in 1996 6.Through treating based on a kind of new method that is used for the treatment of the medicine of vasculitis and vessel embolism more than 2 years, slough comes off, the face that festers healing, clinical cure.Over 6 years, follow up a case by regular visits to, do not see recurrence for 3 times.Late result " excellent ".Telephone number: 0537-2385475.
3, Tian Jinchang, man, 57 years old, people from Zibo City, Shandong Province.Suffer from vasculitis in the time of 37 years old, though through how tame hospitalize, the state of an illness continues to worsen.Right foot first toe rots, and left side foot has four toes to fester, and is in a bad way.Accept in October, 1988 to treat based on a kind of new therapy that is used for the treatment of the medicine of vasculitis and vessel embolism, after 2 years, the face that festers healing, clinical cure.Over 14 years, follow up a case by regular visits to, do not see recurrence for five times.Late result " excellent ".Telephone number: 0537-2388545.
4, Zhang Xiaotian, man, 103 years old, the Tongshan County people of Jiangsu Province.Suffer from atherosclerotic occlusive disease in the time of 99 years old and with the lower limb vascular obturation, the cardiovascular and cerebrovascular vessel ischemia.Do not heal through treatment in 2 years, left the fourth toe festers, and toenail rots, and severe pain is difficult sleeps, and night is with until dawn.Children and grandchildren have carried out shroud, prepare funeral affairs.Accepted treating of Jining vasculitis hospital on January 1st, 2002 based on a kind of new method that is used for the treatment of the medicine of vasculitis and vessel embolism, the face that festers after three months healing, the toenail that rots after 10 months grows again, the ischemia symptom of cardiovascular and cerebrovascular vessel disappears, though old man 103 years old, but as like more than 70 year old people, the walking of walking with vigorous strides is taken care of oneself.Grandsons say happily: " grandfather lived 20 years again, strove for the world venerable old man or lady at advanced age." telephone number: 0516-2760471.

Claims (2)

1, a kind of medicine that is used for the treatment of vasculitis and vessel embolism, form by Radix Ginseng, aspirin, oryzanol and rutin, it is characterized in that a kind of formula proportion that is used for the treatment of the medicine of vasculitis and vessel embolism of the present invention is: Radix Ginseng 77%, aspirin 20%, oryzanol 1% and rutin 2%, the weight of said prescription is: Radix Ginseng 385 grams, aspirin 100 grams, oryzanol 5 grams, rutin 10 grams.
2, a kind of medicine that is used for the treatment of vasculitis and vessel embolism according to claim 1 is characterized in that processing technology is: Radix Ginseng removed impurity, cleans, run through, and section, dry sterilization is pulverized, is sieved, and makes fine powder, i.e. the Radix Ginseng powder; The former powder of aspirin, oryzanol and rutin is sieved respectively, get fine powder and Radix Ginseng powder's mix homogeneously, incapsulate, can be made into 1000 of the said capsules of the present invention by the said formulation weight of claim 1.
CNB2005100435131A 2005-05-12 2005-05-12 Capsule for activating vital energy and promoting blood circulation Expired - Fee Related CN1304017C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100435131A CN1304017C (en) 2005-05-12 2005-05-12 Capsule for activating vital energy and promoting blood circulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100435131A CN1304017C (en) 2005-05-12 2005-05-12 Capsule for activating vital energy and promoting blood circulation

Publications (2)

Publication Number Publication Date
CN1706466A CN1706466A (en) 2005-12-14
CN1304017C true CN1304017C (en) 2007-03-14

Family

ID=35580698

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100435131A Expired - Fee Related CN1304017C (en) 2005-05-12 2005-05-12 Capsule for activating vital energy and promoting blood circulation

Country Status (1)

Country Link
CN (1) CN1304017C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10391096B2 (en) * 2011-10-13 2019-08-27 Quercegen Pharmaceuticals Llc Method for treating thrombotic disorders using quercetin-containing compositions
BR112021010500A2 (en) 2018-11-30 2021-08-24 Beth Israel Deaconess Medical Center, Inc. Method to reduce soluble p-selectin in a cancer patient, method to reduce or prevent thrombus formation in a cancer patient, method to promote tumor regression in a cancer patient, method to stabilize or reduce metastatic cancer in a cancer patient, pharmaceutical composition to reduce soluble p-selectin in a cancer patient, pharmaceutical composition to reduce or prevent thrombus formation in a cancer patient, pharmaceutical composition to promote tumor regression in a cancer patient and pharmaceutical composition to stabilize or reduce metastatic cancer in a cancer patient

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1290547A (en) * 2000-10-23 2001-04-11 岳德恒 Medicine powder for curing angitis and its preparing method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1290547A (en) * 2000-10-23 2001-04-11 岳德恒 Medicine powder for curing angitis and its preparing method

Also Published As

Publication number Publication date
CN1706466A (en) 2005-12-14

Similar Documents

Publication Publication Date Title
CN102335268A (en) Chinese medicine for treating skin diseases
CN100345573C (en) Medicine for treating traumatic injury
CN1733183A (en) Externally applied pharmaceutical for bone fracture
CN1304017C (en) Capsule for activating vital energy and promoting blood circulation
CN102526433B (en) Medicine for treating articular contracture
CN104324100A (en) Traditional Chinese medicine ointment for treating ganglion and preparation method thereof
CN102600272B (en) Traditional Chinese medicine for treatment of orthopedic disease
CN103830325A (en) Traditional Chinese medicine fumigant and nursing method for treating knee osteoarthritis
CN1112206C (en) Bone fracture setting medicine powder
CN104161957A (en) Traditional Chinese medicine composition for treating fracture and delayed fracture healing
CN105920341A (en) Plaster for treating bone injury diseases and preparation method of plaster
CN1814091A (en) External-use Chinese medicine preparation for treating angeitis and diabetes foot
CN108686146A (en) A kind of Dressed plaster promoting blood circulation and removing blood stasis and preparation method thereof
CN103599296B (en) A kind of Chinese medicine for the treatment of prolapse of lumbar intervertebral disc
CN102872278A (en) Vertebra and bone strengthening capsule for treating lumbar spondylosis
CN103520283A (en) Foot bath powder and preparation method thereof
CN103191212A (en) Externally used traditional Chinese medicine powder for treating osteoarthritis and preparation method thereof
CN102258762B (en) Medicinal composition for diminishing swelling and relieving pain and preparation and use thereof
CN100490835C (en) Medicine for treating bone fracture
CN101066335B (en) Chinese medicine for treating thromboangiitis obliterans and phlebitis and its preparation method
CN111529584A (en) A Chinese medicinal composition for treating fracture, arthritis and acute and chronic soft tissue injury, and its preparation method
CN105125822A (en) Traditional Chinese medicine composition for treating postoperative swelling of fracture of lower limb
CN106421098B (en) The external medicine composition for treating various osteonosus
CN1270743C (en) Chinese traditional medicine for treating prolapse of lumbar intervertebral disc
CN104547090A (en) Externally applied traditional Chinese medicine composition for treating arthritis, synovitis and arthroedema

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee